Author:
Wu R-R,Zhang F-Y,Gao K-M,Ou J-J,Shao P,Jin H,Guo W-B,Chan P K,Zhao J-P
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference45 articles.
1. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU . Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 2011; 8: 114–126.
2. Heal DJ, Gosden J, Jackson HC, Cheetham SC, Smith SL . Metabolic consequences of antipsychotic therapy: preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesity. Handb Exp Pharmacol 2012; 212: 135–164.
3. Ruzanna ZZ, Ong LY, Cheah YC, Fairuz A, Marhani M . The association between dyslipidaemia and types of antipsychotic medications among patients with chronic schizophrenia. Med J Malaysia 2012; 67: 39–44.
4. Musil R, Obermeier M, Russ P, Hamerle M . Weight gain and antipsychotics: a drug safety review. Expert Opin Drug Saf 2015; 14: 73–96.
5. Wu RR, Zhao JJ, Liu ZN, Zhai JG, Guo XF, Guo WB et al. Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. Psychopharmacology (Berl) 2006; 186: 572–578.
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献